Lv2
130 积分 2025-09-17 加入
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
1个月前
已完结
Potential biomarkers for immunotherapy in non-small-cell lung cancer
1个月前
已完结
Treatment of Non–Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele Frequency
1个月前
已完结
Prognostic and Diagnostic Value of Circulating Tumor Cells in Patients with Lung Cancer: A Retrospective Study
1个月前
已关闭
The diagnostic value of the combination of carcinoembryonic antigen, squamous cell carcinoma-related antigen, CYFRA 21-1, neuron-specific enolase, tissue polypeptide antigen, and progastrin-releasing peptide in small cell lung cancer discrimination
1个月前
已完结
Cell-free DNA methylation in the clinical management of lung cancer
1个月前
已完结
Improving the screening ability of neuron-specific enolase on small cell lung cancer
2个月前
已完结
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
2个月前
已完结
Biomarker strategy in lung cancer
2个月前
已完结
Molecular Pathology of Lung Cancer
4个月前
已关闭
皖公网安备34019202002308
